Chemotherapy Toxicities
To view the entire topic, please log in or purchase a subscription.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drugs, procedures, and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and PRIME Journals. Explore these free sample topics:
-- The first section of this topic is shown below --
First Things First (assess & treat for the following)
- Attend to the ABCs as the first priority.
- The goal is to understand what chemotherapeutic regimen the patient has received and how it relates to the patient’s critical condition.
- Myelosuppression is the most common toxicity that critical care physicians will encounter.
- All of the chemotherapy agents cause myelosuppression, in addition to other specific toxicities.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
First Things First (assess & treat for the following)
- Attend to the ABCs as the first priority.
- The goal is to understand what chemotherapeutic regimen the patient has received and how it relates to the patient’s critical condition.
- Myelosuppression is the most common toxicity that critical care physicians will encounter.
- All of the chemotherapy agents cause myelosuppression, in addition to other specific toxicities.
There's more to see -- the rest of this topic is available only to subscribers.